These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2105032)

  • 1. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.
    Mirowitz SA; Sartor K; Gado M
    AJR Am J Roentgenol; 1990 Feb; 154(2):369-73. PubMed ID: 2105032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.
    Mirowitz SA; Sartor K; Gado M
    AJNR Am J Neuroradiol; 1989; 10(6):1159-63. PubMed ID: 2512777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spontaneous regression of basal ganglia lesions in a case of neurofibromatosis type 1 (case report)].
    Oztürk M; Ozyazgan I; Mavili E; Orhan S
    Tani Girisim Radyol; 2003 Dec; 9(4):439-42. PubMed ID: 14730952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
    Magnaldi S; White RM; Bryan RN
    Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.
    Terada H; Barkovich AJ; Edwards MS; Ciricillo SM
    AJNR Am J Neuroradiol; 1996 Apr; 17(4):755-60. PubMed ID: 8730197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content.
    Isiklar I; Leeds NE; Fuller GN; Kumar AJ
    AJR Am J Roentgenol; 1995 Dec; 165(6):1503-12. PubMed ID: 7484597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebral MRT in neurofibromatosis: gliosis versus neoplasia?].
    Mautner VF; Pressler M; Fünsterer C; Schneider E
    Rofo; 1989 Aug; 151(2):225-8. PubMed ID: 2548251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major salivary gland lesions: correlation of MR findings with flow cytometric DNA analysis and prognosis.
    Takashima S; Sone S; Horii A; Okamoto S; Yoshida J
    AJR Am J Roentgenol; 1996 Nov; 167(5):1297-304. PubMed ID: 8911200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcification mimicking manganese-induced increased signal intensities in T1-weighted MR images in a patient taking herbal medicine: case report.
    Ahn JH; Yoo CI; Lee CR; Lee JH; Lee H; Kim CY; Park JK; Sakai T; Yoon CS; Kim Y
    Neurotoxicology; 2003 Dec; 24(6):835-8. PubMed ID: 14637378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain.
    DiPaolo DP; Zimmerman RA; Rorke LB; Zackai EH; Bilaniuk LT; Yachnis AT
    Radiology; 1995 Jun; 195(3):721-4. PubMed ID: 7754001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT detection of basal ganglion lesions in neurofibromatosis type 1: correlation with MRI.
    Menor F; Marti-Bonmatí L
    Neuroradiology; 1992; 34(4):305-7. PubMed ID: 1528439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germinomas of the basal ganglia and thalamus: MR findings and a comparison between MR and CT.
    Moon WK; Chang KH; Kim IO; Han MH; Choi CG; Suh DC; Yoo SJ; Han MC
    AJR Am J Roentgenol; 1994 Jun; 162(6):1413-7. PubMed ID: 8192009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cranial MR imaging in patients with von Recklinghausen's disease (neurofibromatosis type I).
    Hashimoto T; Tayama M; Miyazaki M; Kuroda Y; Hiura K; Hujino K; Yamashita K
    Neuropediatrics; 1990 Nov; 21(4):193-8. PubMed ID: 2127081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cranial MR imaging in neurofibromatosis.
    Bognanno JR; Edwards MK; Lee TA; Dunn DW; Roos KL; Klatte EC
    AJR Am J Roentgenol; 1988 Aug; 151(2):381-8. PubMed ID: 3134807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging of spinal neurofibromatosis.
    Li MH; Holtås S
    Acta Radiol; 1991 Jul; 32(4):279-85. PubMed ID: 1907470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of thymic epithelial tumors.
    Kushihashi T; Fujisawa H; Munechika H
    Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral pulvinar signal intensity decrease on T2-weighted images in patients with aspartylglucosaminuria.
    Autti T; Lönnqvist T; Joensuu R
    Acta Radiol; 2008 Jul; 49(6):687-92. PubMed ID: 18568562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR diagnosis of Creutzfeldt-Jakob disease: significance of high signal intensity of the basal ganglia.
    Barboriak DP; Provenzale JM; Boyko OB
    AJR Am J Roentgenol; 1994 Jan; 162(1):137-40. PubMed ID: 8273652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.